Setting the Stage
I went into early August feeling confident.
Selling premium. Collecting credits. Playing the probabilities.
MSTX – The Quick Theta Play That Backfired
I sold this call just two days before the rally. Thought it would be an easy win on a quiet biotech name.
Then MSTX jumped above my breakeven almost immediately. Now I’m nursing a 42% loss in under a week.
SMCX – The Slow Burn That Exploded
Now the short call has more than doubled in price. I’m down $505 — a 117% loss on the risked capital — and today alone it cost me $270.
CHYM – The “Safe” One That’s Not So Safe
CONL – The Lone Bright Spot π
Up $38 (33.63%) so far, and if it keeps this pace, I’ll likely take profits early to avoid any last-minute gamma surprises.
π§ What Went Wrong (and Right)
Mistakes:
-
Overconcentration on one expiration date – All four trades end on 8/15. One bad week hits all positions.
-
No hard exit rules – I didn’t set P/L alerts to automatically cut losers.
-
Underestimating volatility – MSTX and SMCX both moved more than expected without major news.
What Worked with CONL:
-
Entered early enough for theta to accrue.
-
Avoided a volatile name or earnings risk.
-
Stayed disciplined and didn’t over-size.
π§ Damage Control Plan
-
MSTX: Buy back if it breaches $35.50.
-
SMCX: Roll or close if it pulls back to $8.00.
-
CHYM: Close if I can scratch the trade for break-even.
-
CONL: Take profits at 50–60% of max credit.
π‘ Lessons for Future Me (and You)
-
Never stack too many trades on the same expiry.
-
Set automated exit rules — don’t leave it to willpower.
-
Respect sector volatility — biotech and small-caps can run on whispers.
-
Size small enough that one loss doesn’t wreck the month.
No comments:
Post a Comment